Postoperative expression of Cushing disease in a young male: metamorphosis of silent corticotroph adenoma?

2019 ACTH Acanthosis nigricans Adolescent/young adult Asian - Bangladeshi Bangladesh Blood pressure CT scan Central obesity Corticotrophic adenoma Cortisol Cortisol (plasma) Cortisol, free (24-hour urine) Cushing's disease Cushing's syndrome Dexamethasone Dexamethasone suppression (high dose) Dexamethasone suppression (low dose) Dorsocervical fat pad* Dyslipidaemia Error in diagnosis/pitfalls and caveats FSH Facial plethora Facies - moon Fundoscopy* Gamma knife radiosurgery Glucocorticoids Histopathology Hypogonadism Hypogonadotrophic hypogonadism Immunohistochemistry Immunostaining Leukocytosis Liver function MRI Male Non-functioning pituitary adenoma Obesity October Ophthalmology Pathology Pituitary Prolactin Radiotherapy Resection of tumour Striae Supraclavicular fat pads Surgery Testosterone Transsphenoidal surgery Visual disturbance Visual field defect Weight gain

Journal

Endocrinology, diabetes & metabolism case reports
ISSN: 2052-0573
Titre abrégé: Endocrinol Diabetes Metab Case Rep
Pays: England
ID NLM: 101618943

Informations de publication

Date de publication:
01 Oct 2019
Historique:
received: 19 08 2019
accepted: 20 08 2019
entrez: 1 11 2019
pubmed: 2 11 2019
medline: 2 11 2019
Statut: aheadofprint

Résumé

Silent corticotroph adenoma (SCA) is an unusual type of nonfunctioning pituitary adenoma (NFA) that is silent both clinically and biochemically and can only be recognized by positive immunostaining for ACTH. Under rare circumstances, it can transform into hormonally active disease presenting with severe Cushing syndrome. It might often produce diagnostic dilemma with difficult management issue if not thoroughly investigated and subtyped accordingly following surgery. Here, we present a 21-year-old male who initially underwent pituitary adenomectomy for presumed NFA with compressive symptoms. However, he developed recurrent and invasive macroadenoma with severe clinical as well as biochemical hypercortisolism during post-surgical follow-up. Repeat pituitary surgery was carried out urgently as there was significant optic chiasmal compression. Immunohistochemical analysis of the tumor tissue obtained on repeat surgery proved it to be an aggressive corticotroph adenoma. Though not cured, he showed marked clinical and biochemical improvement in the immediate postoperative period. Anticipating recurrence from the residual tumor, we referred him for cyber knife radio surgery. Pituitary NFA commonly present with compressive symptoms such as headache and blurred vision. Post-surgical development of Cushing syndrome in such a case could be either drug induced or endogenous. In the presence of recurrent pituitary tumor, ACTH-dependent Cushing syndrome indicates CD. Rarely a SCA presenting initially as NFA can transform into an active corticotroph adenoma. Immunohistochemical marker for ACTH in the resected tumor confirms the diagnosis.

Identifiants

pubmed: 31671410
doi: 10.1530/EDM-19-0046
pii: EDM190046
pmc: PMC6790907
doi:
pii:

Types de publication

Journal Article

Langues

eng

Références

J Clin Endocrinol Metab. 1996 Feb;81(2):497-502
pubmed: 8636257
Clin Endocrinol (Oxf). 2010 May;72(5):648-53
pubmed: 19650787
Neurosurgery. 2003 Nov;53(5):1076-84; discussion 1084-5
pubmed: 14580274
Neurosurgery. 2012 Feb;70(2):491-6; discussion 496
pubmed: 21822153
Pituitary. 2018 Apr;21(2):183-193
pubmed: 29344907
World Neurosurg. 2018 Jul;115:e464-e471
pubmed: 29678704
Neurosurgery. 2000 Sep;47(3):723-9; discussion 729-30
pubmed: 10981760
Neurosurg Clin N Am. 2012 Oct;23(4):571-86
pubmed: 23040744
J Neurosurg. 1990 Feb;72(2):262-7
pubmed: 2153197
J Neurosurg. 2004 Nov;101(5):874-7
pubmed: 15540932
J Clin Endocrinol Metab. 2006 May;91(5):1796-801
pubmed: 16507632
Clin Endocrinol (Oxf). 1999 Sep;51(3):281-4
pubmed: 10469006
Pituitary. 2002;5(4):221-3
pubmed: 14558669
Br J Neurosurg. 2005 Feb;19(1):38-42
pubmed: 16147581
Am J Med. 1978 Mar;64(3):492-9
pubmed: 76447
Neurosurgery. 2012 Aug;71(2):296-303; discussion 304
pubmed: 22517250
Endocrine. 2017 May;56(2):286-297
pubmed: 27491554
Acta Neurochir (Wien). 2012 Aug;154(8):1493-8
pubmed: 22619024
Eur J Endocrinol. 2010 Jul;163(1):35-43
pubmed: 20385723
Am J Pathol. 1980 Mar;98(3):617-38
pubmed: 6244736
Neurosurgery. 2013 Jul;73(1):8-17; discussion 17-8
pubmed: 23685641
Medicine (Baltimore). 2015 Dec;94(51):e2134
pubmed: 26705201
Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):903-10
pubmed: 25216855
Horm Cancer. 2010 Apr;1(2):80-92
pubmed: 20717480
Eur J Endocrinol. 2010 Aug;163(2):193-200
pubmed: 20460423
Hum Pathol. 2004 Sep;35(9):1137-47
pubmed: 15343517
Endocr J. 2007 Dec;54(5):777-82
pubmed: 17917309

Auteurs

Sharmin Jahan (S)

Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.

M A Hasanat (MA)

Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.

Tahseen Mahmood (T)

Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.

Shahed Morshed (S)

Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.

Raziul Haq (R)

Department of Neurosurgery, Dhaka Medical College and Hospital (DMCH), Dhaka, Bangladesh.

Md Fariduddin (M)

Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.

Classifications MeSH